| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8292661 | Biochemical and Biophysical Research Communications | 2018 | 7 Pages |
Abstract
Neuroligin 2, an inhibitory synaptic protein, modulates a peculiar aspect of vascular function and could represent a novel target of therapy in various fields, from tumor angiogenesis to vascular diseases.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Margherita Pergolizzi, Laura Bizzozero, Elena Riccitelli, Davide Pascal, Anna Valeria Samarelli, Federico Bussolino, Marco Arese,